Atlas Trials

A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

Clinical trial NCT07699328 · RECRUITING

Trial details

NCT number
NCT07699328
Sponsor
Voronoi, Inc
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
EGFR-Mutant Non-Small Cell Lung Cancer
Start date
2024-03-26
Primary completion
2029-01-01
Enrollment
315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.